Celltrion

Celltrion Opens UK Headquarters in Uxbridge

Celltrion UK has officially opened its new UK headquarters at the Charter Building in Uxbridge, UK.

Private Equity Steps up for Baxter Biopharma

A private equity consortium of Warburg Pincus and Advent International is said to be in advanced talks to acquire medical device maker Baxter International’s biopharma solutions business. The deal could be worth $4 billion or more, news agencies and the newspaper Wall Street Journal reported.

News

Baxter Said to Eye Sale of Biopharma CMO Arm

Plans by US healthcare company Baxter International to shed its biopharma contract business as it streamlines operations after a poor 2022 earnings performance are gradually taking concrete shape.

News

European Medicines Agency Pave Way for Biosimilar Drug Breakthrough

Top-Feature

MOC – Event Center Messe München

A successful concept on course for expansion — maintenance Munich 2025

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Nova-Institut GmbH

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Brenntag SE

Brenntag Downsizes Management Board, Retains Both Divisions

Concept Heidelberg

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

CHEManager International c/o Wiley-VCH GmbH

20 Years of CHEManager International

Virtual Event

Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Thomson Reuters

Celltrion